Position in RCEL
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$784
-$3,552 QoQ
Shares Held
190
-83.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 73 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026GAMMA Investing LLC holds $19,478,658 across 78 Medical Devices names. RCEL ranks #69 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
54,716 | $4,964,929 | |
| 2 | SYK |
Stryker Corp
|
7,578 | $2,385,857 | |
| 3 | MDT |
Medtronic plc
|
29,091 | $2,275,788 | |
| 4 | BSX |
Boston Scientific Corp
|
32,958 | $1,406,647 | |
| 5 | EW |
Edwards Lifesciences Corp
|
11,281 | $1,020,479 | |
| 6 | PHG |
Koninklijke Philips NV
|
29,761 | $809,201 | |
| 7 | DXCM |
Dexcom Inc
|
11,492 | $773,986 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
9,971 | $638,243 |
All Filings in RCEL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $784 | 190 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $4,336 | 1,172 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $231 | 67 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $1,926 | 377 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $1,544 | 292 | Shares | Defined | 2025-07-14 | |
| 2024-12-31 | $10,342 | 808 | Shares | Defined | 2025-01-03 | |
| 2024-09-30 | $2,669 | 249 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $586 | 74 | Shares | Defined | 2024-07-02 | |
| 2024-03-31 | $1,266 | 79 | Shares | Defined | 2024-04-05 | |
| 2023-12-31 | $233 | 17 | Shares | Defined | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||